{"code":"E70.2","type":"code","title":"Disorders of tyrosine metabolism","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["transitory tyrosinemia of newborn (P74.5)","androgen insensitivity syndrome (E34.5-)","congenital adrenal hyperplasia (E25.0)","hemolytic anemias attributable to enzyme disorders (D55.-)","Marfan syndrome (Q87.4-)","5-alpha-reductase deficiency (E29.1)"],"excludes2":["Ehlers-Danlos syndromes (Q79.6-)"],"isBillable":false,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":false,"billableFy2027":false},"sibling_codes":["E70.20","E70.21","E70.29"],"inclusionTerms":[],"sibling_titles":{"code":"E70.29","title":"Other disorders of tyrosine metabolism","isBillable":true},"useAdditionalCode":[],"clinicalDefinition":"Disorders of tyrosine metabolism is a non-billable ICD-10-CM category code (E70.2). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): transitory tyrosinemia of newborn (P74.5); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); hemolytic anemias attributable to enzyme disorders (D55.-); Marfan syndrome (Q87.4-); 5-alpha-reductase deficiency (E29.1). Excludes2 (not included here): Ehlers-Danlos syndromes (Q79.6-).","officialDefinition":"Disorders of tyrosine metabolism is a non-billable ICD-10-CM category code (E70.2). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): transitory tyrosinemia of newborn (P74.5); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); hemolytic anemias attributable to enzyme disorders (D55.-); Marfan syndrome (Q87.4-); 5-alpha-reductase deficiency (E29.1). Excludes2 (not included here): Ehlers-Danlos syndromes (Q79.6-).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}